SequelSEC

Bespoke Extracts, Inc. BSPK

Pharmaceutical Preparations · CIK 0001409197 · Fiscal year ends 1231

Revenue
$1.12M
Fiscal year ended 2024-12-31
Operating income
-$994.63K
Fiscal year ended 2024-12-31
Free cash flow
-$889.80K
Fiscal year ended 2024-12-31

Bespoke Extracts, Inc. (BSPK) reported revenue of $1.12M and net income of -$1.04M for the fiscal year ended 2024-12-31. This page shows 6 annual periods of income statement, balance sheet and cash flow figures normalized from Bespoke Extracts, Inc.’s SEC filings, each linked to the filing it came from. It is classified by the SEC under Pharmaceutical Preparations.

Income

Bespoke Extracts, Inc. income by fiscal year, in US dollars, normalized from SEC filings.
Metric2024-12-312023-12-312022-12-312021-08-312019-08-312018-08-31
Revenue$1.12M$785.45K$3.41K$35.57K$62.10K$15.92K
Cost of revenue$664.52K$442.29K$1.15K$13.57K$71.41K$22.92K
Gross profit$452.94K$343.16K$2.26K$22.00K-$9.31K-$7.01K
Operating income-$994.63K-$1.47M-$4.02M-$965.58K$3.01M-$7.19M
Net income-$1.04M-$1.48M-$4.12M-$965.58K$2.58M-$7.61M
Research & developmentUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
Weighted-average diluted sharesshares 10.53Mshares 10.17Mshares 9.37Mshares 5.16Mshares 60.59Mshares 35.41M
Pretax income-$1.04M-$1.48M-$4.12M-$965.58K$2.58M-$7.61M
Income tax expenseUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
Diluted EPS$-0.10$-0.15$-0.44$-0.19$0.04$-0.21
Selling, general & administrative$1.28M$1.59M$3.74M$640.88K-$3.51M$6.77M
General & administrativeUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
Selling & marketingUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable

Balance

Bespoke Extracts, Inc. balance by fiscal year, in US dollars, normalized from SEC filings.
Metric2024-12-312023-12-312022-12-312021-08-312019-08-312018-08-31
Cash & equivalentsUnavailable$6.61K$24.43K$11.18K$10.34K$79.78K
Total assets$359.09K$354.36K$409.59K$124.52K$79.42K$219.79K
Current assets$165.26K$81.84K$111.73K$89.03K$37.60K$174.62K
Total liabilities$2.45M$2.08M$1.08MUnavailable$111.06K$647.33K
Current liabilities$1.12M$1.08M$865.65K$542.76K$111.06K$566.17K
Total equity incl. NCI-$2.09M-$1.72M-$672.10K-$418.24K-$31.63K-$427.54K
Temporary (mezzanine) equityUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
Inventory$32.53K$15.80KUnavailable$48.26K$3.17K$61.86K
Accounts receivable$57.28K$45.23KUnavailable$5.26K$6.45K$2.00K
GoodwillUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
Long-term debtUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
Accounts payableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable

Cash flow

Bespoke Extracts, Inc. cash flow by fiscal year, in US dollars, normalized from SEC filings.
Metric2024-12-312023-12-312022-12-312021-08-312019-08-312018-08-31
Operating cash flow-$289.80K-$415.20K-$798.07K-$1.04M-$492.69K-$747.69K
Capital expenditures$600.00KUnavailable$7.20K$2.74KUnavailableUnavailable
Investing cash flowUnavailableUnavailable-$87.97K-$5.00KUnavailable$90.00K
Financing cash flow$343.50K$397.37K$762.24K$930.53K$423.25K$650.30K
Net change in cashUnavailableUnavailableUnavailable-$115.43K-$69.44K-$7.39K
Stock-based compensation$197.52K$380.38K$2.96MUnavailable-$1.40M$6.51M
Common dividends paidUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
Common share repurchasesUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
Depreciation & amortizationUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable

Derived

Bespoke Extracts, Inc. derived by fiscal year, in US dollars, normalized from SEC filings.
Metric2024-12-312023-12-312022-12-312021-08-312019-08-312018-08-31
Free cash flow-$889.80KUnavailable-$805.27K-$1.04MUnavailableUnavailable
Gross margin40.5%43.7%66.3%61.8%Unavailable-44.0%
Operating margin-89.0%-187.4%-118011.6%-2714.9%Unavailable-45169.7%
FCF margin-79.6%Unavailable-23635.7%-2934.6%UnavailableUnavailable
SBC / revenue17.7%48.4%86747.9%Unavailable-2260.2%40888.2%
Current ratio0.15x0.08x0.13x0.16x0.34x0.31x
Revenue YoY growth42.3%22954.1%UnavailableUnavailable290.1%Unavailable
Net margin-92.8%-188.8%-120816.8%-2714.9%Unavailable-47801.7%
R&D / revenueUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
CapEx / revenue53.7%Unavailable211.4%7.7%UnavailableUnavailable
Long-term debt / equityUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
Effective tax rateUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable

Amounts are abbreviated; the exact reported value is carried in each cell. — means unavailable, not zero. Open BSPK in the interactive workspace to inspect any figure back to its filing.

Source filings

10-Q · Filed 2025-11-12View SEC filing
10-Q · Filed 2025-08-27View SEC filing
10-Q · Filed 2025-06-30View SEC filing
10-K · Filed 2025-04-21View SEC filing
10-Q · Filed 2024-11-13View SEC filing
10-Q · Filed 2024-10-08View SEC filing

Companies in the same industry

Every accounting identity this site checks — the balance sheet, the gross profit bridge and the cash flow statement — reconciles in every period shown.